Dermapharm Holding SE buy Prof
Summary
This prediction ended on 08.07.22 with a price of €51.00. The price of Dermapharm Holding SE has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.04%. Prof has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | -2.672% | -2.672% | -2.423% | -3.507% |
| iShares Core DAX® | -5.868% | -2.496% | 2.292% | 50.129% |
| iShares Nasdaq 100 | 1.660% | 3.513% | 13.191% | 88.484% |
| iShares Nikkei 225® | -6.126% | 2.136% | 27.665% | 53.973% |
| iShares S&P 500 | 0.504% | 2.045% | 9.817% | 60.027% |
Comments by Prof for this prediction
In the thread Dermapharm Holding SE diskutieren
In the thread Trading Dermapharm Holding SE


